T4	Exp 36 56	the kappa B elements
T5	Exp 60 101	the human immunodeficiency virus enhancer
T6	Exp 361 365	them
T7	Exp 216 245	its immunosuppressive effects
T8	Exp 313 318	which
T9	Exp 260 274	the expression
T10	Exp 366 374	the gene
T11	Exp 414 428	the activation
T12	Exp 432 464	the human immunodeficiency virus
T13	Exp 573 575	we
T14	Exp 517 541	the molecular mechanisms
T15	Exp 594 605	the effects
T16	Exp 609 618	this drug
T17	Exp 661 663	we
T18	Exp 671 675	that
T19	Exp 676 689	the formation
T20	Exp 747 766	the kappa B complex
T21	Exp 774 790	the HIV enhancer
T22	Exp 795 813	the NFAT-1 complex
T23	Exp 821 847	the interleukin-2 enhancer
T24	Exp 865 877	the presence
T25	Exp 958 960	it
T26	Exp 886 914	The kappa B-binding activity
T27	Exp 920 936	the HIV enhancer
T28	Exp 978 1008	the mitogen phytohemagglutinin
T29	Exp 1092 1100	the drug
T30	Exp 1127 1132	which
R6	Coref Anaphora:T7 Antecedent:T31
R7	Coref Anaphora:T8 Antecedent:T32
R8	Coref Anaphora:T6 Antecedent:T4
R9	Coref Anaphora:T25 Antecedent:T26
R10	Coref Anaphora:T30 Antecedent:T33
T1	Protein 386 399	interleukin-2
T2	Protein 799 805	NFAT-1
T3	Protein 825 838	interleukin-2
T31	Exp 176 189	Cyclosporin A
T32	Exp 296 312	lymphokine genes
T33	Exp 1116 1123	a model
